Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of a Single Institution.
Fangzheng W, Chuner J, Zhiming Y, Tongxin L, Fengqin Y, Lei W, Bin L, Fujun H, Ming C, Weifeng Q, Zhenfu F. Fangzheng W, et al. Among authors: lei w. Oncol Res. 2018 Mar 5;26(2):277-287. doi: 10.3727/096504017X15079846743590. Epub 2017 Oct 18. Oncol Res. 2018. PMID: 29046165 Free PMC article.
Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma.
Wang F, Chuner J, Lei W, Fengqin Y, Zhimin Y, Quanquan S, Tongxin L, Zhenfu F, Yangming J. Wang F, et al. Among authors: lei w. Medicine (Baltimore). 2020 Sep 25;99(39):e22283. doi: 10.1097/MD.0000000000022283. Medicine (Baltimore). 2020. PMID: 32991429 Free PMC article. Clinical Trial.
Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W, Chuner J, Lei W, Fengqin Y, Zhimin Y, Quanquan S, Tongxin L, Min X, Peng W, Bin L, Aizawa R, Sakamoto M, Zhenfu F. Fangzheng W, et al. Among authors: lei w. Oncotarget. 2017 Aug 7;8(53):91150-91161. doi: 10.18632/oncotarget.20017. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207632 Free PMC article.
Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W, Quanquan S, Chuner J, Lei W, Fengqin Y, Zhimin Y, Tongxin L, Min X, Peng W, Haitao J, Aizawa R, Sakamoto M, Yuezhen W, Zhenfu F. Fangzheng W, et al. Among authors: lei w. Oncotarget. 2017 May 27;8(57):96798-96808. doi: 10.18632/oncotarget.18245. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228572 Free PMC article.
2,189 results